Circulating regulatory B cell subsets in patients with neuromyelitis optica spectrum disorders.

about

Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations.Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?

P2860

Q47104784-2E0D8AA8-9095-4E69-9834-FCDBF43520F2 Q58555322-8B7BB3F6-FCE5-4DD4-9F9B-7293048BED50

P2860

Circulating regulatory B cell subsets in patients with neuromyelitis optica spectrum disorders.

Item

http://www.wikidata.org/entity/Q48302225

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Circulating regulatory B cell ...... tis optica spectrum disorders.

@en

Circulating regulatory B cell ...... tis optica spectrum disorders.

@nl

type

Item

label

Circulating regulatory B cell ...... tis optica spectrum disorders.

@en

Circulating regulatory B cell ...... tis optica spectrum disorders.

@nl

prefLabel

Circulating regulatory B cell ...... tis optica spectrum disorders.

@en

Circulating regulatory B cell ...... tis optica spectrum disorders.

@nl

P1476

Circulating regulatory B cell ...... itis optica spectrum disorders

@en

P2093

Jie Zhu

http://www.w3.org/2001/XMLSchema#string

Jinming Han

http://www.w3.org/2001/XMLSchema#string

Li Sun

http://www.w3.org/2001/XMLSchema#string

Lifang Wang

http://www.w3.org/2001/XMLSchema#string

Xueli Fan

http://www.w3.org/2001/XMLSchema#string

Yang-Yang Song

http://www.w3.org/2001/XMLSchema#string

Zhongkun Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

Role of regulatory b cells in neuroimmunologic disorders

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Interleukin 35-Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases.

Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis.

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.

Decrease in proportion of CD19+ CD24(hi) CD27+ B cells and impairment of their suppressive function in Graves' disease.

Helminth infections associated with multiple sclerosis induce regulatory B cells.

P2888

s10072-017-2932-7

P304

1205-1212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10072-017-2932-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jinming Han

P577

2017-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28389940

http://www.w3.org/2001/XMLSchema#string

Circulating regulatory B cell subsets in patients with neuromyelitis optica spectrum disorders.

about

P2860

P2860

Circulating regulatory B cell subsets in patients with neuromyelitis optica spectrum disorders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698